Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.



Signify Premium Insight: Pursuing Partners – GE’s Handshake with Elekta

Signify Premium Insights Subscription Required

14th April 2022 – GE Healthcare is partnering with Elekta in the field of radiation oncology, enabling a more joined-up offering across imaging and treatment. The move may prove fruitful for GE, but at whose expense?

Signify Premium Insight: Autonomous AI Debate Reiterates Importance of Radiologists

Signify Premium Insights Subscription Required

12th April 2022 – After almost dying out, the debate about AI replacing radiologists risks being reignited thanks to the approval of an autonomous rule-out solution from Oxipit. So, does the clearance mean that AI has been transformed?

Signify Premium Insight: VC’s $3.6bn in a Quickly Maturing Market

Signify Premium Insights Subscription Required

8th April 2022 – Since 2015, Venture Capital investors have poured almost $3.6bn into the medical imaging AI market. Signify Research’s recently released report identified the trends within this funding. This Premium Insight looks at these trends in more detail, and assesses their implications.

Signify Premium Insight: How Soon Is Now for Butterfly Network?

Signify Premium Insights Subscription Required

6th April 2022 – Butterfly Network has recently hit a difficult spell. As well as facing lawsuits from both investors and competitors the vendor’s share price is near an all-time low and it has lowered its guidance. Despite all these clouds, is there yet a silver lining?

Signify Premium Insight: FDA Approval for Samsung NeuroLogica as Interest in Photon Counting CT Grows

Signify Premium Insights Subscription Required

31st March 2022 – Photon counting represents the next great technological leap for CT, unlocking new possibilities for the modality. As yet, only two vendors have had their systems cleared by the FDA, with a very different approach taken by each.